Adil I. Khan

1.8k total citations
31 papers, 1.3k citations indexed

About

Adil I. Khan is a scholar working on Immunology and Allergy, Molecular Biology and Physiology. According to data from OpenAlex, Adil I. Khan has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology and Allergy, 6 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in Adil I. Khan's work include Clinical Laboratory Practices and Quality Control (6 papers), Cell Adhesion Molecules Research (6 papers) and Proteoglycans and glycosaminoglycans research (3 papers). Adil I. Khan is often cited by papers focused on Clinical Laboratory Practices and Quality Control (6 papers), Cell Adhesion Molecules Research (6 papers) and Proteoglycans and glycosaminoglycans research (3 papers). Adil I. Khan collaborates with scholars based in United States, Canada and United Kingdom. Adil I. Khan's co-authors include Naheed Mahmood, Ming Jin, Paul Kubes, Andrew Burke, Bryan Heit, Cosimo Pìzza, Sonia Piacente, Alan Hay, Graciela Andonegui and J. A. V. Butler and has published in prestigious journals such as Immunity, The Journal of Immunology and Biochemical and Biophysical Research Communications.

In The Last Decade

Adil I. Khan

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adil I. Khan United States	15	338	254	150	142	132	31	1.3k
Rocío López-Posadas Germany	22	554 1.6×	475 1.9×	195 1.3×	142 1.0×	75 0.6×	37	1.8k
Shinji Higa Japan	14	451 1.3×	336 1.3×	94 0.6×	115 0.8×	218 1.7×	30	1.5k
Laura M’Rabet Netherlands	22	617 1.8×	312 1.2×	118 0.8×	189 1.3×	197 1.5×	32	1.8k
Mokarram Hossain Canada	19	319 0.9×	462 1.8×	102 0.7×	88 0.6×	63 0.5×	36	1.3k
Mehran Haidari United States	19	395 1.2×	403 1.6×	344 2.3×	52 0.4×	116 0.9×	31	1.4k
Elvira Bailón Spain	19	879 2.6×	183 0.7×	89 0.6×	341 2.4×	55 0.4×	37	1.6k
Cristina Castellote Spain	25	349 1.0×	283 1.1×	261 1.7×	287 2.0×	90 0.7×	65	1.7k
Shanmugam Nagarajan United States	31	819 2.4×	685 2.7×	348 2.3×	127 0.9×	184 1.4×	62	2.3k
María A. Hidalgo Chile	24	582 1.7×	592 2.3×	140 0.9×	65 0.5×	35 0.3×	57	1.7k
Javier Martı́nez-Botas Spain	22	947 2.8×	117 0.5×	213 1.4×	47 0.3×	104 0.8×	72	2.0k

Countries citing papers authored by Adil I. Khan

Since Specialization

Citations

This map shows the geographic impact of Adil I. Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adil I. Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adil I. Khan more than expected).

Fields of papers citing papers by Adil I. Khan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adil I. Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adil I. Khan. The network helps show where Adil I. Khan may publish in the future.

Co-authorship network of co-authors of Adil I. Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Adil I. Khan. A scholar is included among the top collaborators of Adil I. Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adil I. Khan. Adil I. Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pillay, Tahir S, Adil I. Khan, & Sedef Yenice. (2025). Artificial intelligence (AI) in point-of-care testing. Clinica Chimica Acta. 574. 120341–120341. 7 indexed citations

Khan, Adil I., et al.. (2025). Unmasking the underlying cause: A rash with deeper implications. Allergy and Asthma Proceedings. 46(6). 512–514.

Khan, Adil I., et al.. (2024). Not all marketed skin cleansers’ pH is optimal for atopic dermatitis. Allergy and Asthma Proceedings. 45(4). 284–287. 2 indexed citations

Khan, Adil I., et al.. (2024). A survey of intelligent reflecting surfaces: Performance analysis, extensions, potential challenges, and open research issues. Vehicular Communications. 51. 100859–100859. 4 indexed citations

Plebani, Mario, James H. Nichols, Peter B. Luppa, et al.. (2024). Point-of-care testing: state-of-the art and perspectives. Clinical Chemistry and Laboratory Medicine (CCLM). 63(1). 35–51. 32 indexed citations

Wang, Xu, Xiaolong Wang, Peng Wang, et al.. (2022). Comparison of BNT162b2-, mRNA-1273- and Ad26.COV2.S-Elicited IgG and Neutralizing Titers against SARS-CoV-2 and Its Variants. Vaccines. 10(6). 858–858. 2 indexed citations

Zhang, Biao, Le Guo, Yu Liu, et al.. (2021). Exosomes Transport Anti-Human Immunodeficiency Virus Factors from Human Cervical Epithelial Cells to Macrophages. Journal of Innate Immunity. 13(5). 269–279. 7 indexed citations

Jones, Jessica, et al.. (2017). Multiple Myeloma: The Case of the Disappearing Band. Laboratory Medicine. 49(1). 87–91. 1 indexed citations

Polson, Julie, Frank H. Wians, Paul J. Orsulak, et al.. (2008). False positive acetaminophen concentrations in patients with liver injury. Clinica Chimica Acta. 391(1-2). 24–30. 27 indexed citations

10.

Khan, Adil I., et al.. (2006). Modified Plasma-Based Ecarin Clotting Time Assay for Monitoring of Recombinant Hirudin During Cardiac Surgery. American Journal of Clinical Pathology. 125(2). 290–295. 9 indexed citations

11.

Khan, Adil I., et al.. (2005). Modified Plasma-Based Ecarin Clotting Time Assay for Monitoring of Recombinant Hirudin During Cardiac Surgery. American Journal of Clinical Pathology. 125(2). 290–295. 1 indexed citations

12.

Khan, Adil I., Bryan Heit, Graciela Andonegui, Pina Colarusso, & Paul Kubes. (2005). Lipopolysaccharide: A p38 MAPK‐Dependent Disrupter of Neutrophil Chemotaxis. Microcirculation. 12(5). 421–432. 35 indexed citations

13.

Khan, Adil I., Steven M. Kerfoot, Bryan Heit, et al.. (2004). Role of CD44 and Hyaluronan in Neutrophil Recruitment. The Journal of Immunology. 173(12). 7594–7601. 161 indexed citations

14.

Kubes, Paul, Bryan Heit, Guido van Marle, et al.. (2003). In Vivo Impairment of Neutrophil Recruitment during Lentivirus Infection. The Journal of Immunology. 171(9). 4801–4808. 30 indexed citations

15.

Khan, Adil I., R. Clive Landis, & Rajneesh Malhotra. (2003). L-Selectin Ligands in Lymphoid Tissues and Models of Inflammation. Inflammation. 27(5). 265–280. 31 indexed citations

16.

Venturi, Guglielmo M., Lili Tu, Takafumi Kadono, et al.. (2003). Leukocyte Migration Is Regulated by L-Selectin Endoproteolytic Release. Immunity. 19(5). 713–724. 131 indexed citations

17.

Khan, Adil I. & Paul Kubes. (2003). L‐Selectin: An Emerging Player in Chemokine Function. Microcirculation. 10(3-4). 351–358. 17 indexed citations

18.

Khan, Adil I., Dorian O. Haskard, Rajneesh Malhotra, & R. Clive Landis. (2002). Identification and characterization of L‐selectin ligands in porcine lymphoid tissues. Immunology. 105(4). 441–449. 4 indexed citations

19.

Mahmood, Naheed, Sonia Piacente, Cosimo Pìzza, et al.. (1996). The Anti-HIV Activity and Mechanisms of Action of Pure Compounds Isolated fromRosa damascena. Biochemical and Biophysical Research Communications. 229(1). 73–79. 171 indexed citations

20.

Houghton, Peter J., Tibebe Z. Woldemariam, Adil I. Khan, Andrew Burke, & Naheed Mahmood. (1994). Antiviral activity of natural and semi-synthetic chromone alkaloids. Antiviral Research. 25(3-4). 235–244. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact